CCIA
ABUS icon

Campbell & Co Investment Adviser’s Arbutus Biopharma ABUS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
230,534
+127,122
+123% +$558K 0.06% 512
2026
Q1 		$465K Sell
103,412
-9,701
-9% -$42.4K 0.03% 774
2025
Q4 		$544K Buy
113,113
+39,828
+54% +$179K 0.03% 790
2025
Q3 		$333K Buy
+73,285
New +$269K 0.03% 877

Other funds holding ABUS

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WMA
Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Campbell & Co Investment Adviser's ABUS Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Arbutus Biopharma (ABUS) stake by 123% in Q2 2026, buying an estimated $558K and bringing the position to 230,534 shares worth $1.11M. The position accounts for 0.06% of the portfolio, ranked #512.

Campbell & Co Investment Adviser first reported a position in ABUS in Q3 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Campbell & Co Investment Adviser held 230,534 shares of Arbutus Biopharma worth $1.11M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 127,122 Arbutus Biopharma shares in Q2 2026, an estimated $558K.
  • Arbutus Biopharma made up 0.06% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #512 holding.
  • Campbell & Co Investment Adviser first reported a position in Arbutus Biopharma in Q3 2025 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.